[恶性瘤和移植] [恶性瘤和移植]
Sibylle von Vietinghoff1, Steffen Manekeller2,3, Guido Fechner4,3
1Medizinische Klinik und Poliklinik I, Universitätsklinikum Bonn und Universität Bonn, Venusberg Campus 1, Gebäude 27, 53127, Bonn, Deutschland. sibylle.von_vietinghoff@ukbonn.de.
Innere Medizin (Heidelberg, Germany)
|July 29, 2025
概括
固体器官移植接受者面临某些癌症的风险增加,需要警监测和量身定制的治疗策略. 移植后恶性瘤的管理需要仔细考虑免疫抑制和抗癌疗法.
科学领域:
- 瘤学和移植医学 移植医学
- 免疫抑制和癌症生物学
背景情况:
- 恶性瘤是疾病和死亡的重要原因.
- 移植候选人需要彻底查,接受者需要警监督.
- 活跃癌症通常排除患者从固体器官移植,除了局部肝脏瘤的例外.
研究的目的:
- 审查在实体器官移植接受者中管理癌症的挑战和考虑.
- 突出移植后恶性瘤的发病率增加和独特特征.
- 讨论免疫抑制管理与癌症治疗并行的复杂性.
主要方法:
- 关于实体器官移植接受者的恶性瘤现有文献的综述.
- 对特定癌症类型及其移植后发病率的分析.
- 讨论治疗策略,包括化疗和免疫疗法.
主要成果:
- 移植后的恶性瘤往往表现出加速的进展.
- 观察到皮肤癌和与病毒相关的瘤 (例如,PTLD) 的发病率较高.
- 细胞癌的发病率在移植后增加,影响原生脏.
- 化疗需要调整剂量,因为药物动力学相互作用.
- 免疫疗法可以诱导异种移植的排斥.
结论:
- 对于患有癌症的移植接受者来说,个性化管理计划至关重要.
- 与免疫抑制和器官功能平衡抗癌治疗是必不可少的.
- 需要持续的研究来完善这些复杂案例的管理策略.
更多相关视频
相关概念视频
Bone Marrow Sampling and Transplants
502
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
502
Tissue Transplantation
521
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
521
Cell-mediated Immune Responses
72.9K
Overview
72.9K


